Contract Research

JPT Peptide Technologies is an ISO 9001:2015 certified and GCLP compliant innovative service provider and research & development partner.
JPT’s proprietary peptide technologies help to advance projects for a variety of applications such as

  • Development of vaccines and immunotherapies
  • Immune monitoring and diagnostic content research
  • Seromarker discovery and validation
  • Vaccine target and epitope discovery peptide lead discovery and systematic peptide optimization
  • Discovery, clinical and functional proteomics 
Drug Discovery

Why partner with JPT?

JPT is the preferred partner for peptide related projects because of its:

  • Proprietary technologies for peptide synthesis and high throughput screening
  • Integrated in-house R&D team for organic and medicinal chemistry, immunology and assay development, structural biology, bioinformatics and data management
  • Solid track record of successful R&D projects
  • Flexible business arrangements for collaborative projects
  • ISO 9001:2015 and GCLP regulated quality assurance system
  • Professional project management and communication

What we offer

JPT offers its services and contract research and development project participation in flexible business arrangements.

Our Business Models are:

  • Fee-for-service projects
  • FTE based and milestone driven collaboration projects
  • Shared risk, partnered development projects
  • Participation on publicly granted R&D projects (SME qualification)

Our Track Record

JPT has run several successful projects in different scientific fields:

Immunotherapy & Vaccines

  • Peptide selection and synthesis for individualized neo-epitope based vaccination strategies
  • Peptide pool design and synthesis for adoptive cell transfer therapy
  • Design of comprehensive peptide libraries for companion diagnostics and treatment
  • Identification of serological predictive, prognostic, and surrogate biomarkers
  • Proteome-spanning vaccine target discovery
  • Deep T-cell epitope discovery


  • Development of next generation standards for targeted proteomics
  • Characterization of specificity profiles for proteins and protein families
  • Design and synthesis of peptide libraries for proteome wide detection and quantification of proteins
  • Development of molecular probes for the multiplexed detection and quantification of proteins from biological samples
  • Discovery of proteotypic peptide markers for functional proteomics
  • Identification of epigenetic states of proteins and characterization of enzymatic alterations

Drug Discovery

  • Design and production of screening libraries, peptides and peptidomimetics
  • Identification and optimization of agonistic and antagonistic ligands
  • Identification and optimization of affinity ligands
  • Identification and optimization of stabilizing peptides as excipients
  • Development of surrogate bioassays for antigen-free detection of therapeutic protein
  • Substrate identification and optimization for several orphan enzymes for screening assays

Partner with us

Contact: Tanja Kaan
T: +49-30-6392-7878
X: +49-30-6392-7888

Who we are

Our team comprises over 100 highly trained and skilled employees of which many are holding a university degree in natural sciences. Our know-how ranges from biomarker discovery and immunology to proteomics, vaccine and drug development.

Where we are

All our production and research facilities are located in the Technology Park Adlershof in Berlin, Germany serving a worldwide customer base.

Quality Assurance

All production is performed according to ISO 9001:2015 standards

Stay in touch and be the first to receive the latest news!